Christophe Blockeel continues the endometrial theme, now for frozen transfer (FRET): which endometrial preparation for transferring a thawed embryo gives the best outcome.
Three basic approaches are contrasted: the natural cycle, the artificial (HRT) cycle and the modified-natural cycle. Each has its own logic of controllability, physiology and risk.
The artificial cycle is simple and convenient for timing — estrogen prepares the endometrium, progesterone opens the implantation window, and the transfer day is easy to plan. But convenience comes at a price.
The key figure of the talk is the miscarriage rate: in artificial cycles it is higher than in natural ones, roughly 40% versus 25%. This is a fundamental difference that tilts the choice toward physiology.
The mechanism is the same as for fresh transfer: an HRT cycle has no corpus luteum and none of the vasoactive factors it produces, which affects placentation and obstetric outcomes.
Blockeel ties transfer timing to the day from progesterone start: blastocyst transfer falls on day 5, 6 or 7 of progesterone support — and the precision of this window is critical.
A one-day error in either direction shifts the synchrony of embryo and endometrium, lowering the chance of implantation; hence the importance of standardisation and, where possible, progesterone monitoring.
Natural and modified-natural cycles bring the corpus luteum back into play, which is more physiological and, by accumulated data, safer in obstetric terms — at the cost of more demanding monitoring.
The logic here is not a universal protocol but a match to the uterine phenotype: where there is adenomyosis, "standard" HRT yields to a prepared regimen with suppression.
The practical conclusion: choosing a FRET protocol is a balance of controllability and safety. The artificial cycle is convenient but raises the risk of loss; natural schemes are more physiological but need finer monitoring.
Blockeel urges against prescribing HRT by default to everyone, and for weighing obstetric risks and uterine features, especially in patients who ovulate and those with adenomyosis.
Blockeel separately stresses that the "planning convenience" of the artificial cycle must not outweigh obstetric safety: the difference in miscarriage rate and pre-eclampsia risk is not an abstraction but outcomes for which the team managing the pregnancy is later responsible.
The upshot: the best preparation for frozen transfer is one that accounts for corpus-luteum physiology and the endometrial phenotype; for many patients this is a shift from the artificial cycle to a natural or modified one, and in adenomyosis to a prepared, down-regulated regimen.
HRT, modified natural or true natural cycle — which preparation actually delivers the best obstetric outcomes? A practical synthesis of recent data on E2 duration, progesterone route and timing, day-of-transfer monitoring, and the new NPP protocol that may reshape weekend scheduling.
Reproductive endocrinologist and gynecologist, and Medical Director of Brussels IVF — the Centre for Reproductive Medicine at University Hospital Brussels (UZ Brussel). Professor at the Vrije Universiteit Brussel and visiting professor at the University of Zagreb, with more than 20 years in reproductive medicine. His work focuses on ovarian stimulation, embryo transfer and assisted reproductive technologies, with more than 300 scientific publications.
Author of the lecture "Endometrial preparation for frozen embryo transfer"